Racial Disparities Among Lung Transplant Survivors—Shadows and Substance

Adegunsoye, Ayodeji; Saunders, Milda R.

doi:10.1001/jamanetworkopen.2023.8285

Cited by 1 publication

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients of Black ethnicity are less likely than those of White ethnicity to have lung transplantation and have worse outcomes even when controlling for confounding factors, socio-economic status (as per the area deprivation index – ADI), donor cause of death, blood type nor HLA mismatch ( 71 , 72 ). Further research to determine if ethnic differences or socio-economic disparities drive outcomes in FPF are needed ( 73 ).…”

Section: Disparities and Barriers To Genomic Testingmentioning

confidence: 99%

Genetic and environmental factors in interstitial lung diseases: current and future perspectives on early diagnosis of high-risk cohorts

2023

View full text Add to dashboard Cite

Within the wide scope of interstitial lung diseases (ILDs), familial pulmonary fibrosis (FPF) is being increasingly recognized as a specific entity, with earlier onset, faster progression, and suboptimal responses to immunosuppression. FPF is linked to heritable pathogenic variants in telomere-related genes (TRGs), surfactant-related genes (SRGs), telomere shortening (TS), and early cellular senescence. Telomere abnormalities have also been identified in some sporadic cases of fibrotic ILD. Air pollution and other environmental exposures carry additive risk to genetic predisposition in pulmonary fibrosis. We provide a perspective on how these features impact on screening strategies for relatives of FPF patients, interstitial lung abnormalities, ILD multi-disciplinary team (MDT) discussion, and disparities and barriers to genomic testing. We also describe our experience with establishing a familial interstitial pneumonia (FIP) clinic and provide guidance on how to identify patients with telomere dysfunction who would benefit most from genomic testing.

show abstract

Section: Disparities and Barriers To Genomic Testingmentioning

confidence: 99%